Early prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis

Early prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis - Early prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046931

Enrollment

2000

Registered

2022-02-18

Start date

2022-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled to undergo ERCP

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo ERCP and with their age at least 20 years old.

Exclusion criteria

Exclusion criteria: Patients with acute pancreatitis at the time of ERCP and patients with severe renal impairment.

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of urine trypsinogen-2 immediately after and 1 hour after ERCP. Comparison of an effectiveness of urine trypsinogen-2 and blood test 3 hours after ERCP. Effectiveness of a predictive model of post-ERCP pancreatitis.	—

Countries

Japan

Contacts

Public ContactRintaro Fukuda

The University of Tokyo Hospital, Tokyo, Japan Department of Gastroenterology

rintaro.fukuda@gmail.com03-3815-5411

Outcome results